pretickt

Humana Inc. (HUM)

Healthcare · end-of-day data as of Oct 16, 2026

Humana Inc.
HUM · $49.63B
$413.16+6.1%last 60 sessions · close Oct 16, 2026
$162.46$433.5052 weeks
Buy · 29 analystsPT $477.98 +15.7%
  • P/E vs own+46.8%
  • P/E vs sector+39.0%
  • Target upside+15.7%
  • Off 52w high-4.7%
  • InsidersNone in 90d
  • FCF yield-0.9%
  • Earnings in21d
  • Trendsideways
  • Sector▲ +16.0%
  • RSI54
  • MA20×50—
  • Volume0.9x
  • Support-1.7%
  • Resistance—

The average 12-month analyst price target for HUM is $477.98, 15.7% above the last close of $413.16 on Oct 16, 2026; targets range from $301.34 to $664.90. Rating consensus: Buy.

Snapshot

  • P/E39.1x
  • P/E vs sector+39.0%
  • P/E vs own+46.8%
  • Target upside+15.7%
  • ConsensusBuy
  • Market cap$49.63B
  • FCF yield-0.9%
  • InsidersNone in 90d
  • Earnings in21d
  • News

Why it moved

Humana Inc. (HUM) fell 4.4% on Oct 16, 2026.

The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move is specific to HUM.

Market (SPY)-1.1%
Healthcare sector+0.4%
HUM specific-3.7%

1 story on the day (30-day average 1.4).

Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.

Price and events

⇔⇕$180$259$337$416Oct 25Jan 26Apr 26Jul 26Oct 26EADAAEADEADAEAAAAAADE

Last close $413.16 · +56.3% over 1y · E earnings · D dividend · S split · A analyst rating change

Technicals

  • Trendsideways
  • Sector▲ +16.0%
  • MAs20▲ 50▲ 100▲ 200▲
  • Above MAs4 of 4 above
  • MA20×50—
  • RSI54
  • Support-1.7%
  • Resistance—
  • Off 52w high-4.7%
  • Off ATH-23.5%
  • 52w range$413.16
  • Bollingerupper half
  • MACD3.01
  • ATR+4.4%
  • Volume0.9x

Analyst price targets

Low$301.34
Average$477.98
Median$477.72
High$664.90
Upside+15.7%

19 firms with a target in the last 12 months · last close $413.16 · as of Oct 16, 2026

⇔⇕$122$264$406$549$691Oct 25Mar 26Aug 26Jan 27Jun 27-36%-21%-60%-42%-52%-53%-38%+4%-22%+26%+22%+60%
— actual price● bullish target● bearish targethover a dot to see the analysts behind it · wheel or drag to move through time · drag the price axis on the right to stretch it · double-click resets

Strong buy 3 · Buy 13 · Hold 12 · Sell 1 · Strong sell 0

Revenue and free cash flow

Q2 FY2026: Revenue +26.2% year over year, free cash flow -1.4% of revenue, operating margin 3.3%.

RevenueFree cash flow
Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026
Q2 FY2026Jun 30, 2026$40.87B5.72-$558M13.5%3.3%1.7%
Q1 FY2026Mar 31, 2026$39.65B9.83$1.13B15.0%4.0%3.0%
Q4 FY2025Dec 31, 2025$32.52B-6.61-$1.85B11.7%-3.2%-2.4%
Q3 FY2025Sep 30, 2025$32.65B1.62$836M14.3%0.3%0.6%
Q2 FY2025Jun 30, 2025$32.39B4.51$1.16B14.9%2.2%1.7%
Q1 FY2025Mar 31, 2025$32.11B10.30$236M17.4%5.1%3.9%
Q4 FY2024Dec 31, 2024$29.21B-5.76-$682M13.1%-3.1%-2.4%
Q3 FY2024Sep 30, 2024$29.4B3.98$1.73B14.5%2.2%1.6%

Peers

20D
1UNHUnitedHealth Group Incorporated$401.43-1.3%-7.4%+14.6%22.9$360B
2CVSCVS Health Corp.$92.36-0.2%-16.0%+20.9%24.4$118B
3ELVElevance Health Inc.$428.260.0%0.0%+1.9%19.0$92.88B
4CICigna Corporation$302.30+1.2%-0.2%+10.9%12.5$79.88B
5EWEdwards Lifesciences Corporation$86.60-1.7%-9.0%+15.2%49.8$49.9B
6HUMHumana Inc.$413.16-4.4%-4.7%+15.7%39.1$49.63B
7AAgilent Technologies, Inc.$172.97-1.5%-1.5%+0.5%34.0$48.77B
8CNCCentene Corp.$69.16-1.9%-1.9%-0.5%—$34.16B

Data as of Oct 16, 2026 close.

Latest news

Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.